HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1270458Generated: October 31, 2026
Triphenylphosphine → (3R)-1-t-butoxycarbonyl-3-[4-(imidazol-1-yl)phenoxy]piperidine
https://huagongshe.com/reaction/1270458
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triphenylphosphine | HCID 11776 | — |
| Reactant | 1-(p-Hydroxyphenyl)imidazole | HCID 82315 | — |
| Reactant | (R)-1-Boc-3-hydroxypiperidine | HCID 1514398 | — |
| Reactant | Diethyl azodicarboxylate | HCID 5462977 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | (3R)-1-t-butoxycarbonyl-3-[4-(imidazol-1-yl)phenoxy]piperidine | HCID 69367678 | 6.7% |
Reaction Steps
To a mixture of (3R)-1-t-butoxycarbonyl-3-hydroxypiperidine (4.10 g, 17.8 mmol), 4-(imidazol-1-yl)phenol (4.4 g, 1.5 eq.), triphenylphosphine (1.5 eq., 7.10 g), DMF (80 mL) was added DEAD (1.5 eq., 4.33 mL). The resulting reaction mixture were stirred at room temperature for two days. The solvent was evaporated, the residue was diluted with ethyl acetate, washed with 1N NaOH (45 mL×3), water and brine, and evaporated in vacuo. Purification by flash column chromatography on silical gel with gradient 1–3% methanol in CH2Cl2 gave (3R)-1-t-butoxycarbonyl-3-[4-(imidazol-1-yl)phenoxy]piperidine (420 mg, 1.19 mmol), which was treated with trifluoroacetic acid/CH2Cl2 (1:1) from 0° C. to ambient temperature for 2 hours. The solvents were evaporated. The residue was diluted with CH2Cl2, and washed with 1N HCl (10 mL). The aqueous phase was extracted with CH2Cl2 to remove by-product. The aqueous phase was re-adjusted to pH 9.5 to 10.0 with 1N NaOH. Extraction with CH2Cl2 (60 mL×3) and evaporation of the solvent in vacuo gave (3R)-3-[4-(imidazol-1-yl)phenoxy]piperidine (62 mg) as an oil.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07202263B2 |
|---|
| Source dataset | uspto-grants-2007_04 |
|---|
| ORD ID | ord-97151720506241c3abe4d5cb151879bb |
|---|
| Source note | uspto-grants-2007_04 |
|---|